title: Treatment of hepatitis C.
abstract: With > 100 million people infected worldwide and > or = 4 million people infected in the United States, hepatitis C virus (HCV) is a major public health concern. In the United States, HCV is the most common cause of chronic liver disease. End-stage liver disease from chronic HCV is the most common indication for liver transplantation.
authors.affiliation: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
authors.forename: S
authors.initials: S
authors.lastname: Satoor
authors.forename: J P
authors.initials: JP
authors.lastname: Raufman
mesh_terms: D000465:Algorithms; D000998:Antiviral Agents / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D011788:Quality of Life; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons